Clinical and neuropathologic findings in a woman with the FMR1 premutation and multiple sclerosis

Archives of Neurology

Volumn 65, Issue 8, 2008, Pages 1114-1116

  Greco, Claudia M ^a   Tassone, Flora ^a   Garcia Arocena, Dolores ^a   Tartaglia, Nicole ^c   Coffey, Sarah M ^c   Vartanian, Timothy K ^d   Brunberg, James A ^b   Hagerman, Paul J ^a   Hagerman, Randi J ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CRYSTALLIN; BETA CRYSTALLIN; FRAGILE X MENTAL RETARDATION PROTEIN; INTERFERON BETA SERINE; METHOTREXATE; MITOXANTRONE;

ADULT; ARTICLE; ATAXIA; AUTOPSY; CASE REPORT; CAUSE OF DEATH; FEMALE; FRAGILE X ASSOCIATED TREMOR ATAXIA SYNROME; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; IMMUNOHISTOCHEMISTRY; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; TREMOR; X CHROMOSOME LINKED DISORDER;

ADULT; FATAL OUTCOME; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HUMANS; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; MUTATION;

EID: 49449111126     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.65.8.1114     Document Type: Article

References (12)

1. Ferguson B, Matyszak MK, Esiri MM, Perry VH. Axonal damage in acute multiple sclerosis lesions. Brain. 1997;120(pt 3):393-399.
2. Hagerman PJ, Hagerman RJ. The fragile-X premutation: a maturing perspective. Am J Hum Genet. 2004;74(5):805-816.
3. Coffey SM, Cook K, Tartaglia N, et al. Expanded clinical phenotype of women with the FMR1 premutation. Am J Med Genet A. 2008;16(8):1009-1016.
4. Greco CM, Berman RF, Martin RM, et al. Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain. 2006;129(pt 1):243-255.
5. Iwahashi CK, Yasui DH, An HJ, et al. Protein composition of the intranuclear inclusions of FXTAS. Brain. 2006;129(pt 1):256-271.
6. Arocena DG, Iwahashi CK, Won N, et al. Induction of inclusion formation and disruption of lamin A/C structure by premutation CGG-repeat RNA in human cultured neural cells. Hum Mol Genet. 2005;14(23):3661-3671.
7. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald criteria." Ann Neurol. 2005;58(6):840-846.
8. Hall DA, Berry-Kravis E, Jacquemont S, et al. Initial diagnoses given to persons with the fragile X associated tremor/ataxia syndrome (FXTAS). Neurology. 2005;65(2):299-301.
9. Perng MD, Cairns L, van den IJssel P, Prescott A, Hutcheson AM, Quinlan RA. Intermediate filament interactions can be altered by HSP27 and αB-crystallin. J Cell Sci. 1999;112(pt 13):2099-2112.
10. Salvador-Silva M, Ricard CS, Agapova OA, Yang P, Hernandez MR. Expression of small heat shock proteins and intermediate filaments in the human optic nerve head astrocytes exposed to elevated hydrostatic pressure in vitro. J Neurosci Res. 2001;66(1):59-73.
11. αB-crystallin as candidate autoantigen in multiple sclerosis. Nature. 1995;375(6534):798-801.
12. αB-crystallin in autoimmune demyelination. Nature. 2007;448(7152):474-479.